CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 52 enrolled
Drug / intervention
Coagulation functiondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02392247
NCT02392247N/ACompleted
CompareCT.gov

Hemosonics- VCU Cardiac Surgery Clinical Study Protocol

Virginia Commonwealth University·observational·Posted Mar 18, 2015·Updated Jul 12, 2016

In Brief

An observational study evaluating Coagulation function for Cardiopulmonary Bypass. Completed, enrolled 52 participants across 1 site.

Detailed Summary

This study compares the results of current standard coagulation measurement devices to the Quantra System, a new device, using small amount of extra blood obtained during routine blood draws in cardiac surgery patients.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiopulmonary Bypass
CountriesUnited States
CollaboratorsHemoSonics LLC

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 18, 2015
Enrollment StartApr 1, 2015
Primary CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 11.3 years ago

Interventions

Coagulation functiondevice

Coagulation function assessment tools TEG (standard of practice) vs SEER Quantra (novel coagulation function device)